Publication | Closed Access
The Growth-Inhibitory Effects of Dexamethasone on Renal Cell Carcinoma<i>In Vivo</i>and<i>In Vitro</i>
30
Citations
17
References
2008
Year
DEX treatment is a candidate for advanced RCC therapy by inhibiting the activation of NF-kappa B and its downstream products such as IL-6, IL-8 and VEGF.
| Year | Citations | |
|---|---|---|
Page 1
Page 1